Prevnar 13 Faces Two Disparate Challenges At Advisory Committee
This article was originally published in The Pink Sheet Daily
Executive Summary
Next-generation pneumococcal vaccine failed to show non-inferiority on several serotypes, and there is little scientific consensus about the criteria for its second proposed indication, otitis media.